Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
February 2, 2021
Patent Application Number
16403793
Date Filed
May 6, 2019
Patent Primary Examiner
Patent abstract
The invention relates to compounds and their use in the treatment of disease. Novel irreversible inhibitors of wild-type and mutant forms of EGFR, FGFR, ALK, ROS, JAK, BTK, BLK, ITK, TEC, and/or TXK and their use for the treatment of cell proliferation disorders are described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
